Literature DB >> 12510215

Acute psychiatric admission and menstrual cycle phase in women with schizophrenia.

N Bergemann1, P Parzer, I Nagl, B Salbach, B Runnebaum, Ch Mundt, F Resch.   

Abstract

The clinical observation of a possible relation between the phases of the menstrual cycle and psychotic illness dates well back to the beginning of the nineteenth century. This relation is considered to provide further evidence for the protective effect of oestrogens in schizophrenic women and is summarised by the so-called oestrogen hypothesis. In addition, the hypoestrogenism hypothesis postulates a hypofunction of the gonads in women with schizophrenia with subsequent oestrogen deficiency syndrome. The aim of the present clinical study was to answer the question whether there is a perimenstrual increase in hospital admissions of women suffering from an exacerbation of schizophrenia. Two samples of premenopausal women with schizophrenia were investigated (sample 1: n = 115; sample 2: n = 170). In both samples there was a significant increase in admissions in the perimenstrual phase - three days before and three days after the first day of the menses (sample 1: P = 0.002, sample 2: P = 0.028, binomial test). 37.4% of the patients were admitted during the perimenstrual phase of the cycle in sample 1, 31.8% in sample 2. Regarding age, age at onset, and duration of illness, no difference was found between the group admitted to hospital during the perimenstrual phase versus the group admitted during the rest of the menstrual cycle in either of the samples. The results are discussed in relation to the possibly underlying physiological mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12510215     DOI: 10.1007/s00737-002-0004-2

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  10 in total

1.  Menstrual Cycle in Schizophrenic Patients: Review with a Case.

Authors:  İpek Sönmez; Ferdi Köşger
Journal:  Noro Psikiyatr Ars       Date:  2015-12-01       Impact factor: 1.339

Review 2.  Sex steroids and schizophrenia.

Authors:  Julie A Markham
Journal:  Rev Endocr Metab Disord       Date:  2012-09       Impact factor: 6.514

Review 3.  Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: Are gonadal hormones the link?

Authors:  Andrea Gogos; Luke J Ney; Natasha Seymour; Tamsyn E Van Rheenen; Kim L Felmingham
Journal:  Br J Pharmacol       Date:  2019-03-14       Impact factor: 8.739

4.  Can age at sexual maturity act as a predictive biomarker for prodromal negative symptoms?

Authors:  Seethalakshmi Ramanathan; Jean Miewald; Debra Montrose; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2015-03-14       Impact factor: 4.939

5.  Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.

Authors:  Niels Bergemann; Peter Parzer; Susanne Jaggy; Beatrice Auler; Christoph Mundt; Sabine Maier-Braunleder
Journal:  Schizophr Bull       Date:  2007-12-21       Impact factor: 9.306

6.  [Exacerbation of a schizoaffective psychosis after in vitro fertilization with leuproreline acetate].

Authors:  F Abu-Tair; T Strowitzki; N Bergemann
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

Review 7.  Why estrogens matter for behavior and brain health.

Authors:  Liisa A M Galea; Karyn M Frick; Elizabeth Hampson; Farida Sohrabji; Elena Choleris
Journal:  Neurosci Biobehav Rev       Date:  2016-03-31       Impact factor: 8.989

8.  Exacerbation of Psychosis During the Perimenstrual Phase of the Menstrual Cycle: Systematic Review and Meta-analysis.

Authors:  Thomas J Reilly; Vanessa C Sagnay de la Bastida; Dan W Joyce; Alexis E Cullen; Philip McGuire
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

9.  Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia.

Authors:  Nana Li; Ping Yang; Mimi Tang; Yong Liu; Wenbin Guo; Bing Lang; Jianjian Wang; Haishan Wu; Hui Tang; Yan Yu; Xiangxin Wu; Cuirong Zeng; Ting Cao; Hualin Cai
Journal:  Schizophrenia (Heidelb)       Date:  2022-02-25

Review 10.  A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings.

Authors:  Andrea Gogos; Alyssa M Sbisa; Jeehae Sun; Andrew Gibbons; Madhara Udawela; Brian Dean
Journal:  Int J Endocrinol       Date:  2015-09-27       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.